论文部分内容阅读
目的:探讨血脂康治疗老年人血脂异常的疗效及安全性。方法:122例老年血脂异常患者随机分为康复治疗组60例和对照组62例,两组均给予饮食控制,治疗组在此基础上加用血脂康口服。8周后观察分析血脂变化情况及不良反应。结果:治疗组疗效明显优于对照组,未发现不良反应。结论:血脂康治疗老年人血脂异常是有效并且安全的。
Objective: To investigate the efficacy and safety of Xuezhikang in treating elderly patients with dyslipidemia. Methods: A total of 122 elderly patients with dyslipidemia were randomly divided into rehabilitation treatment group (n = 60) and control group (n = 62). Both groups were given diet control. The treatment group was given Xuezhikang oral. After 8 weeks of observation and analysis of changes in blood lipids and adverse reactions. Results: The treatment group was significantly better than the control group, no adverse reactions were found. Conclusion: Xuezhikang treatment of elderly dyslipidemia is effective and safe.